WebPOAI 2HR test Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. WebMar 5, 2024 · POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge …

Predictive Oncology Announces $7.2 Million Registered Direct …

WebEAGAN, Minn., July 26, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business... POAI : 0.3611 … WebEither POAI is the direct beneficiary of the WIPO patent, or is guaranteed unlimited access, and protection and to exploit the intellectual property contained in it. Once this has … bold type series 6

2024-05-16 NDAQ:POAI Press Release Predictive ... - stockhouse

WebMay 16, 2024 · Predictive Oncology ( NASDAQ: POAI) enters issuance and sale agreement regarding certain stock purchase warrants, that are expected to result in gross proceeds … WebJun 14, 2024 · MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company … Webregister a public offering, usually where there is no present intention to immediately sell all the securities being registered. A shelf registration statement permits multiple offerings … bold type tickets login